JP Morgan Chase
IRD

JP Morgan Chase’s Opus Genetics IRD Stock Holding History

JP Morgan Chase’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.1K Buy
+22,199
New +$104K ﹤0.01% 6133
2025
Q2 		– Sell
-58
Closed -$57 – 7802
2025
Q1 		$57 Buy
+58
New +$65 ﹤0.01% 6964
2023
Q4 		– Sell
-8,474
Closed -$28.4K – 7934
2023
Q3 		$28.4K Buy
+8,474
New +$34K ﹤0.01% 5978
2022
Q4 		– Sell
-15,600
Closed -$31K – 7075
2022
Q3 		$31K Buy
+15,600
New +$33.7K ﹤0.01% 5691
2014
Q2 		– Sell
-169
Closed -$88K – 3641
2014
Q1 		$88K Buy
+169
New +$91.4K ﹤0.01% 3492

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JP Morgan Chase's IRD Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Opus Genetics (IRD) in Q2 2026: 22,199 shares worth $90.1K. The stake represents ﹤0.01% of the portfolio and ranks #6133 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in IRD as recently as Q1 2025.

JP Morgan Chase first reported a position in IRD in Q1 2014 and has held it in 5 quarters since. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • JP Morgan Chase held 22,199 shares of Opus Genetics worth $90.1K as of Q2 2026.
  • Opus Genetics was a new JP Morgan Chase position in Q2 2026.
  • Opus Genetics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6133 holding.
  • JP Morgan Chase first reported a position in Opus Genetics in Q1 2014 and has held it in 5 quarters since.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.